Anti-CD20 B cell depletion in immune intervention of central nervous system autoimmune disease

被引：0

作者：

Weber, Martin ^{[1
]}

Prod'homme, Thomas ^{[1
]}

Karnezis, Tara ^{[2
]}

Patarroyo, Juan ^{[1
]}

Rundle, Cynthia ^{[1
]}

Danilenko, Dimitry ^{[3
]}

Slavin, Anthony ^{[1
]}

Linington, Christopher ^{[4
]}

Bernard, Claude ^{[2
]}

Martin, Flavius ^{[3
]}

Zamvil, Scott ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] Monash Univ, Melbourne, Vic 3004, Australia

[3] Genentech Inc, San Francisco, CA 94080 USA

[4] Univ Aberdeen, Aberdeen, Scotland

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2008年 / 203卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：164 / 164

页数：1

共 50 条

[21] Uncovering the underhanded: B-cell depletion therapies and severe viral infections - Commentary on 'Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease'
Tanasescu, Radu
Gran, Bruno
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (02) : 323 - 324
[22] Effects of anti-CD20 treatment beyond B cell depletion: Reduction of endogenous sTACI
Mader, Simone
Thaler, Franziska
Fichtner, Miriam
Ho, Samantha
Oswald, Eva
Wong, Hoi Kiu
Vural, Atay
Yilmaz, Vuslat
Tuezuen, Erdem
Turkoglu, Recai
Straub, Tobias
Smolle, Michalea
Schaller, Jonas
Feederle, Regina
Bultmann, Andreas
Schneider, Pascal
Meinl, Ingrid
Kuempfel, Tania
Meinl, Edgar
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 592 - 593
[23] The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
Cooper, N
Stasi, R
Cunningham-Rundles, SS
Feuerstein, MA
Leonard, JP
Amadori, S
Bussel, JB
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) : 232 - 239
[24] Targeted B-cell depletion using rituximab (anti-CD20) in recalcitrant autoimmune urticaria: Efficacy, safety, and mechanisms of action
Bingham, C. O., III
Jones, P. E.
Gober, L. M.
Eckman, J. A.
Sterba, P. M.
Saini, S. S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S172 - S172
[25] Imaging and Therapy with Rituximab Anti-CD20 Immunotherapy in an Animal Model of Central Nervous System Lymphoma
Muldoon, Leslie L.
Lewin, Seth J.
Dosa, Edit
Kraemer, Dale F.
Pagel, Michael A.
Doolittle, Nancy D.
Neuwelt, Edward A.
CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2207 - 2215
[26] Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
Tokunaga, Mikiko
Saito, Kazuyoshi
Kawabata, Daisuke
Imura, Yoshitaka
Fujii, Takao
Nakayamada, Shingo
Tsujimura, Shizuyo
Nawata, Masao
Iwata, Shigeru
Azuma, Taeko
Mimori, Tsuneyo
Tanaka, Yoshiya
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 470 - 475
[27] B cell depletion by anti-CD20 antibodies entrains trabecular bone loss in mice.
Kolomansky, Albert
Deshet-Unger, Naamit
Ostrovsky, Alina
Hiram-Bab, Sahar
Ben-Califa, Nathalie
Liron, Tamar
Oster, Howard S.
Mittelman, Moshe
Gabet, Yankel
Neumann, Drorit
JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S310 - S310
[28] B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
Leandro, Maria J.
ARTHRITIS RESEARCH & THERAPY, 2013, 15
[29] Pharmacological B Cell Depletion by Anti-CD20 Antibody Induces Trabecular Bone Loss in Mice
Kolomansky, Albert
Deshet-Unger, Naamit
Ostrovsky, Alina
Ben-Califa, Nathalie
Hiram-Bab, Sahar
Liron, Tamar
Oster, Howard
Mittelman, Moshe
Gabet, Yankel
Neumann, Drorit
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S377 - S378
[30] Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis
Roll, Petra
Palanichamy, Arumugam
Kneitz, Christian
Dorner, Thomas
Tony, Hans-Peter
ARTHRITIS AND RHEUMATISM, 2006, 54 (08): : 2377 - 2386

← 1 2 3 4 5 →